[Chemotherapy in the elderly]
- PMID: 14624340
- DOI: 10.1007/s00120-003-0446-9
[Chemotherapy in the elderly]
Abstract
The incidence of cancer is age-related and increases rapidly. The age itself is not a contraindication for chemotherapy. Essential is the evaluation of comorbidity and the functional status of the elderly. Due to the physiologic decline in renal function and hepatic drug metabolism with age, the doses of chemotherapeutic agents should be adapted in the elderly. The elderly remain underrepresented in clinical trials. In the absence of comprehensive data on treatment in the elderly, it can be expected that response rates and toxicity to chemotherapy will be the same as in younger patients.
Similar articles
-
Chemotherapy in elderly patients with advanced lung cancer. Part I: General aspects and treatment of small cell lung cancer (SCLC).Onkologie. 2004 Oct;27(5):500-5. doi: 10.1159/000080373. Onkologie. 2004. PMID: 15585983 Review.
-
[Chemotherapy of advanced urological tumors].Onkologie. 2003 Oct;26 Suppl 4:13-7. doi: 10.1159/000074740. Onkologie. 2003. PMID: 14605451 Review. German.
-
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer.Urol Oncol. 2014 Jan;32(1):30.e15-21. doi: 10.1016/j.urolonc.2012.11.001. Epub 2013 Feb 18. Urol Oncol. 2014. PMID: 23428534
-
Chemotherapy in the elderly: pharmacologic considerations.Cancer Control. 2000 Nov-Dec;7(6):548-56. doi: 10.1177/107327480000700606. Cancer Control. 2000. PMID: 11088063 Review.
-
Risk-adapted, dose escalation study of weekly docetaxel in the first-line treatment of elderly patients with advanced cancer.J Geriatr Oncol. 2013 Apr;4(2):122-7. doi: 10.1016/j.jgo.2012.11.002. Epub 2012 Dec 14. J Geriatr Oncol. 2013. PMID: 24071537 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources